{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:19:12Z","timestamp":1760141952639,"version":"build-2065373602"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94251","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:52:51Z","timestamp":1760075571000},"source":"Crossref","is-referenced-by-count":0,"title":["Predicting Histopathological Outcomes from Cystoscopic Findings in Newly Diagnosed Bladder Cancer: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Mudasir Ahmad","family":"Tantray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tufeel Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad Ahmad","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad Ahmad","family":"Para","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saqib","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Rouf","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif Hamid","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saundarya","family":"Kumar Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdous Ahmad","family":"Beigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Shakeeb","family":"Arsalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk M","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al.. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022, 81:75-94. 10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part B: Prostate and bladder tumours","volume":"70","author":"Humphrey PA","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part B: Prostate and bladder tumours. Eur Urol. 2016, 70:106-19. 10.1016\/j.eururo.2016.02.028","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang SS","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, et al.. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol. 2016, 196:1021-9. 10.1016\/j.juro.2016.06.049","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.10.087","article-title":"No good options","volume":"185","author":"Smith JA Jr","year":"2011","unstructured":"Smith JA Jr. No good options. J Urol. 2011, 185:8-9. 10.1016\/j.juro.2010.10.087","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: A global overview and recent trends","volume":"71","author":"Antoni S","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 2017, 71:96-108. 10.1016\/j.eururo.2016.06.010","journal-title":"Eur Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester RJ","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, et al.. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006, 49:466-77. 10.1016\/j.eururo.2005.12.031","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman HB","year":"2012","unstructured":"Grossman HB, Stenzl A, Fradet Y, et al.. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012, 188:58-62. 10.1016\/j.juro.2012.03.007","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger M","year":"2013","unstructured":"Burger M, Grossman HB, Droller M, et al.. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013, 64:846-54. 10.1016\/j.eururo.2013.03.059","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.08.026","article-title":"A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: Three-year follow-up results","volume":"58","author":"Zhao Z","year":"2010","unstructured":"Zhao Z, Zeng G, Zhong W, Mai Z, Zeng S, Tao X. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: Three-year follow-up results. Eur Urol. 2010, 58:752-8. 10.1016\/j.eururo.2010.08.026","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)","volume":"74","author":"Panebianco V","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, et al.. Multiparametric magnetic resonance imaging for bladder cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018, 74:294-306. 10.1016\/j.eururo.2018.04.029","journal-title":"Eur Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat AM","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, et al.. Bladder cancer. Lancet. 2016, 388:2796-810. 10.1016\/S0140-6736(16)30512-8","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417611-predicting-histopathological-outcomes-from-cystoscopic-findings-in-newly-diagnosed-bladder-cancer-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:52:57Z","timestamp":1760075577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417611-predicting-histopathological-outcomes-from-cystoscopic-findings-in-newly-diagnosed-bladder-cancer-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.94251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}